Clearside Biomedical
CLSD
CLSD
48 hedge funds and large institutions have $23M invested in Clearside Biomedical in 2019 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 8 increasing their positions, 11 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
27% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 11
86% less call options, than puts
Call options by funds: $254K | Put options by funds: $1.83M
Holders
48
Holding in Top 10
–
Calls
$254K
Puts
$1.83M
Top Buyers
| 1 | +$898K | |
| 2 | +$519K | |
| 3 | +$441K | |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$382K |
| 5 |
Renaissance Technologies
New York
|
+$257K |
Top Sellers
| 1 | -$364K | |
| 2 | -$183K | |
| 3 | -$85.5K | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$71K |
| 5 |
WS
Wedbush Securities
Los Angeles,
California
|
-$60K |